19 Artículos relativos a Compuestos Heterocíclicos de 1 Anillo

• Chemical and biological properties of a cationic Tc-tetraamine complex.
  Publicado en Int J Appl Radiat Isot
• The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates.
  Publicado en Int J Rad Appl Instrum B
• The determination of nitroaromatics and nitramines in ground and drinking water by wide-bore capillary gas chromatography.
  Publicado en J Chromatogr Sci
• Synthesis and renal excretion of technetium-99m-labeled organic cations.
  Publicado en J Nucl Med
• Mutagenicity of trinitrotoluene and its metabolites formed during composting.
  Publicado en J Toxicol Environ Health
• Investigations of N-linked macrocycles for 111In and 90Y labeling of proteins.
  Publicado en Int J Rad Appl Instrum B
• Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
  Publicado en Cancer Res
• Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.
  Publicado en Cancer Res
• Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates.
  Publicado en Bioconjug Chem
• Examples of evolution of microstructure in ceramics and composites.
  Publicado en Microsc Res Tech
• Isolation of three hexahydro-1,3,5-trinitro-1,3,5-triazine-degrading species of the family Enterobacteriaceae from nitramine explosive-contaminated soil.
  Publicado en Appl Environ Microbiol
• Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.
  Publicado en Bioconjug Chem
• Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
  Publicado en Br J Cancer
• Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).
  Publicado en Cancer
• A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
  Publicado en Bioconjug Chem
• Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
  Publicado en Cancer Res
• Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice.
  Publicado en J Nucl Med
• Investigations on the synthesis and properties of some N-[4-phenyl(2-pyrimidinyl)-1-piperazinyl]alkyl (hydroxyalkyl)-3,4-pyridinedicarboximides.
  Publicado en Acta Pol Pharm
• Antibody responses to macrocycles in lymphoma.
  Publicado en J Nucl Med